Recent developments in innervation imaging using iodine-123- metaiodobenzylguanidine scintigraphy in Lewy body diseases

Giorgio Treglia, Ernesto Cason, Anna Gabellini, Alessandro Giordano, Giorgio Fagioli

Research output: Contribution to journalArticle

Abstract

Radiolabeled metaiodobenzylguanidine (MIBG) is an analog of guanethidine and is taken up by the postganglionic presynaptic nerve endings. MIBG uptake in the heart correlates with adrenergic function, which can be reduced in Lewy body diseases. We described the recent developments in innervation imaging using 123I-MIBG scintigraphy in Lewy body diseases including Parkinson's disease and dementia with Lewy bodies. Particularly, we underlined the role of MIBG scintigraphy in differential diagnosis of movement disorders. As described by recent studies, MIBG scintigraphy is a valuable diagnostic tool for differentiation between Lewy body diseases and parkinsonian syndromes or other movement disorders with parkinsonism. Furthermore, this method may provide a powerful differential diagnostic tool between dementia with Lewy bodies and Alzheimer's disease. We also reported the results of clinical investigations about the correlation between characteristics of Parkinson's disease and myocardial MIBG uptake.

Original languageEnglish
Pages (from-to)417-422
Number of pages6
JournalNeurological Sciences
Volume31
Issue number4
DOIs
Publication statusPublished - Aug 2010

Fingerprint

Lewy Body Disease
Radionuclide Imaging
Iodine
Movement Disorders
Parkinsonian Disorders
Parkinson Disease
Guanethidine
Presynaptic Terminals
Adrenergic Agents
Dementia
Alzheimer Disease
Differential Diagnosis

Keywords

  • Innervation imaging
  • Lewy body diseases
  • Metaiodobenzylguanidine
  • Movement disorders
  • Parkinson's disease

ASJC Scopus subject areas

  • Clinical Neurology
  • Psychiatry and Mental health
  • Dermatology
  • Medicine(all)

Cite this

Recent developments in innervation imaging using iodine-123- metaiodobenzylguanidine scintigraphy in Lewy body diseases. / Treglia, Giorgio; Cason, Ernesto; Gabellini, Anna; Giordano, Alessandro; Fagioli, Giorgio.

In: Neurological Sciences, Vol. 31, No. 4, 08.2010, p. 417-422.

Research output: Contribution to journalArticle

Treglia, Giorgio ; Cason, Ernesto ; Gabellini, Anna ; Giordano, Alessandro ; Fagioli, Giorgio. / Recent developments in innervation imaging using iodine-123- metaiodobenzylguanidine scintigraphy in Lewy body diseases. In: Neurological Sciences. 2010 ; Vol. 31, No. 4. pp. 417-422.
@article{c2453e746db3486e8bae00ed1594f3cf,
title = "Recent developments in innervation imaging using iodine-123- metaiodobenzylguanidine scintigraphy in Lewy body diseases",
abstract = "Radiolabeled metaiodobenzylguanidine (MIBG) is an analog of guanethidine and is taken up by the postganglionic presynaptic nerve endings. MIBG uptake in the heart correlates with adrenergic function, which can be reduced in Lewy body diseases. We described the recent developments in innervation imaging using 123I-MIBG scintigraphy in Lewy body diseases including Parkinson's disease and dementia with Lewy bodies. Particularly, we underlined the role of MIBG scintigraphy in differential diagnosis of movement disorders. As described by recent studies, MIBG scintigraphy is a valuable diagnostic tool for differentiation between Lewy body diseases and parkinsonian syndromes or other movement disorders with parkinsonism. Furthermore, this method may provide a powerful differential diagnostic tool between dementia with Lewy bodies and Alzheimer's disease. We also reported the results of clinical investigations about the correlation between characteristics of Parkinson's disease and myocardial MIBG uptake.",
keywords = "Innervation imaging, Lewy body diseases, Metaiodobenzylguanidine, Movement disorders, Parkinson's disease",
author = "Giorgio Treglia and Ernesto Cason and Anna Gabellini and Alessandro Giordano and Giorgio Fagioli",
year = "2010",
month = "8",
doi = "10.1007/s10072-010-0239-z",
language = "English",
volume = "31",
pages = "417--422",
journal = "Neurological Sciences",
issn = "1590-1874",
publisher = "Springer-Verlag Italia s.r.l.",
number = "4",

}

TY - JOUR

T1 - Recent developments in innervation imaging using iodine-123- metaiodobenzylguanidine scintigraphy in Lewy body diseases

AU - Treglia, Giorgio

AU - Cason, Ernesto

AU - Gabellini, Anna

AU - Giordano, Alessandro

AU - Fagioli, Giorgio

PY - 2010/8

Y1 - 2010/8

N2 - Radiolabeled metaiodobenzylguanidine (MIBG) is an analog of guanethidine and is taken up by the postganglionic presynaptic nerve endings. MIBG uptake in the heart correlates with adrenergic function, which can be reduced in Lewy body diseases. We described the recent developments in innervation imaging using 123I-MIBG scintigraphy in Lewy body diseases including Parkinson's disease and dementia with Lewy bodies. Particularly, we underlined the role of MIBG scintigraphy in differential diagnosis of movement disorders. As described by recent studies, MIBG scintigraphy is a valuable diagnostic tool for differentiation between Lewy body diseases and parkinsonian syndromes or other movement disorders with parkinsonism. Furthermore, this method may provide a powerful differential diagnostic tool between dementia with Lewy bodies and Alzheimer's disease. We also reported the results of clinical investigations about the correlation between characteristics of Parkinson's disease and myocardial MIBG uptake.

AB - Radiolabeled metaiodobenzylguanidine (MIBG) is an analog of guanethidine and is taken up by the postganglionic presynaptic nerve endings. MIBG uptake in the heart correlates with adrenergic function, which can be reduced in Lewy body diseases. We described the recent developments in innervation imaging using 123I-MIBG scintigraphy in Lewy body diseases including Parkinson's disease and dementia with Lewy bodies. Particularly, we underlined the role of MIBG scintigraphy in differential diagnosis of movement disorders. As described by recent studies, MIBG scintigraphy is a valuable diagnostic tool for differentiation between Lewy body diseases and parkinsonian syndromes or other movement disorders with parkinsonism. Furthermore, this method may provide a powerful differential diagnostic tool between dementia with Lewy bodies and Alzheimer's disease. We also reported the results of clinical investigations about the correlation between characteristics of Parkinson's disease and myocardial MIBG uptake.

KW - Innervation imaging

KW - Lewy body diseases

KW - Metaiodobenzylguanidine

KW - Movement disorders

KW - Parkinson's disease

UR - http://www.scopus.com/inward/record.url?scp=77958115294&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77958115294&partnerID=8YFLogxK

U2 - 10.1007/s10072-010-0239-z

DO - 10.1007/s10072-010-0239-z

M3 - Article

C2 - 20221656

AN - SCOPUS:77958115294

VL - 31

SP - 417

EP - 422

JO - Neurological Sciences

JF - Neurological Sciences

SN - 1590-1874

IS - 4

ER -